APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exenatide Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Exenatide Injection Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchExenatide Injection Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Exenatide Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Exenatide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exenatide Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Exenatide Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Exenatide Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exenatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exenatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exenatide Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exenatide Injection include Lilly, Chenfei Pharmaceutical, Baxter Pharmaceutical, AstraZeneca and Amylin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exenatide Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exenatide Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exenatide Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exenatide Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Exenatide Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exenatide Injection Market by Company

Lilly

Chenfei Pharmaceutical

Baxter Pharmaceutical

AstraZeneca

Amylin

Exenatide Injection Segment by Type

1.2 ml/Cartridge

2.4 ml/Cartridge

Exenatide Injection Segment by Application

Hospital

Clinic

Pharmacy

Exenatide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exenatide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exenatide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exenatide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exenatide Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Exenatide Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1.2 ml/Cartridge Table 2. Major Company of 2.4 ml/Cartridge Table 3. Global Exenatide Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Exenatide Injection Sales by Type (2021-2026) & (k units) Table 5. Global Exenatide Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Exenatide Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Exenatide Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Exenatide Injection Sales by Type (2027-2032) & (k units) Table 10. Global Exenatide Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Exenatide Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Exenatide Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Exenatide Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Exenatide Injection Sales by Type (2021-2026) & (k units) Table 15. North America Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Exenatide Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Exenatide Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Exenatide Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Exenatide Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Exenatide Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Exenatide Injection Industry Trends Table 25. Exenatide Injection Industry Drivers Table 26. Exenatide Injection Industry Opportunities and Challenges Table 27. Exenatide Injection Industry Restraints Table 28. Global Exenatide Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Exenatide Injection Revenue Market Share by Company (2021-2026) Table 30. Global Exenatide Injection Sales by Company (2021-2026) & (k units) Table 31. Global Exenatide Injection Sales Share by Company (2021-2026) Table 32. Global Exenatide Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Exenatide Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Exenatide Injection Major Company Production Sites and Headquarters Table 35. Global Exenatide Injection Company, Product Type & Application Table 36. Global Exenatide Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Exenatide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Exenatide Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Exenatide Injection Sales by Region (2021-2026) & (k units) Table 41. Global Exenatide Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Exenatide Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Exenatide Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Exenatide Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Exenatide Injection Sales by Region (2027-2032) & (k units) Table 46. Global Exenatide Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Exenatide Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Exenatide Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Exenatide Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Exenatide Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Exenatide Injection Sales by Application (2021-2026) & (k units) Table 52. Global Exenatide Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Exenatide Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Exenatide Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Exenatide Injection Sales by Application (2027-2032) & (k units) Table 57. Global Exenatide Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Exenatide Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Exenatide Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Exenatide Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Exenatide Injection Sales by Application (2021-2026) & (k units) Table 62. North America Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Exenatide Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Exenatide Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Exenatide Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Exenatide Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Exenatide Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Lilly Company Information Table 72. Lilly Business Overview Table 73. Lilly Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Lilly Exenatide Injection Product Portfolio Table 75. Lilly Recent Development Table 76. Chenfei Pharmaceutical Company Information Table 77. Chenfei Pharmaceutical Business Overview Table 78. Chenfei Pharmaceutical Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Chenfei Pharmaceutical Exenatide Injection Product Portfolio Table 80. Chenfei Pharmaceutical Recent Development Table 81. Baxter Pharmaceutical Company Information Table 82. Baxter Pharmaceutical Business Overview Table 83. Baxter Pharmaceutical Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Baxter Pharmaceutical Exenatide Injection Product Portfolio Table 85. Baxter Pharmaceutical Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Exenatide Injection Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Amylin Company Information Table 92. Amylin Business Overview Table 93. Amylin Exenatide Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Amylin Exenatide Injection Product Portfolio Table 95. Amylin Recent Development Table 96. North America Exenatide Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Exenatide Injection Sales by Country (2021-2026) & (k units) Table 98. North America Exenatide Injection Sales Market Share by Country (2021-2026) Table 99. North America Exenatide Injection Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Exenatide Injection Sales Market Share Forecast by Country (2027-2032) Table 101. North America Exenatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Exenatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Exenatide Injection Market Share by Country (2021-2026) Table 104. North America Exenatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Exenatide Injection Market Share Forecast by Country (2027-2032) Table 106. Europe Exenatide Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Exenatide Injection Sales by Country (2021-2026) & (k units) Table 108. Europe Exenatide Injection Sales Market Share by Country (2021-2026) Table 109. Europe Exenatide Injection Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Exenatide Injection Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Exenatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Exenatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Exenatide Injection Market Share by Country (2021-2026) Table 114. Europe Exenatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Exenatide Injection Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Exenatide Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Exenatide Injection Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Exenatide Injection Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Exenatide Injection Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Exenatide Injection Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Exenatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Exenatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Exenatide Injection Market Share by Country (2021-2026) Table 124. Asia-Pacific Exenatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Exenatide Injection Market Share Forecast by Country (2027-2032) Table 126. Latin America Exenatide Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Exenatide Injection Sales by Country (2021-2026) & (k units) Table 128. Latin America Exenatide Injection Sales Market Share by Country (2021-2026) Table 129. Latin America Exenatide Injection Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Exenatide Injection Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Exenatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Exenatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Exenatide Injection Market Share by Country (2021-2026) Table 134. Latin America Exenatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Exenatide Injection Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Exenatide Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Exenatide Injection Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Exenatide Injection Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Exenatide Injection Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Exenatide Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Exenatide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Exenatide Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Exenatide Injection Market Share by Country (2021-2026) Table 144. Middle East and Africa Exenatide Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Exenatide Injection Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Exenatide Injection Distributors List Table 149. Exenatide Injection Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Exenatide Injection Image Figure 2. Global Exenatide Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exenatide Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Exenatide Injection Sales (2021-2032) & (k units) Figure 5. 1.2 ml/Cartridge Image Figure 6. Global 1.2 ml/Cartridge Sales YoY Growth (2021-2032) & (k units) Figure 7. 2.4 ml/Cartridge Image Figure 8. Global 2.4 ml/Cartridge Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Exenatide Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Exenatide Injection Market Share by Type 2025 VS 2032 Figure 11. North America Exenatide Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Exenatide Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Exenatide Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Exenatide Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Exenatide Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Exenatide Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Exenatide Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Exenatide Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Exenatide Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Exenatide Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Exenatide Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Exenatide Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Exenatide Injection Market Share by Application 2025 VS 2032 Figure 31. North America Exenatide Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Exenatide Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Exenatide Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Exenatide Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Exenatide Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Exenatide Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Exenatide Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Exenatide Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Exenatide Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Exenatide Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Exenatide Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Exenatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Exenatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Exenatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Exenatide Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Exenatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Exenatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Exenatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Exenatide Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Exenatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Exenatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Exenatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Exenatide Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Exenatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Exenatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Exenatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Exenatide Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Exenatide Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Exenatide Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Exenatide Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Exenatide Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Exenatide Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 1.2 ml/Cartridge
  • 2.4 ml/Cartridge
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Lilly
  • Chenfei Pharmaceutical
  • Baxter Pharmaceutical
  • AstraZeneca
  • Amylin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exenatide Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Exenatide Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Exenatide Injection Market by Type
  6. 1.3.1 1.2 ml/Cartridge
  7. 1.3.2 2.4 ml/Cartridge
  8. 1.4 Global Exenatide Injection Market Size by Type
  9. 1.4.1 Global Exenatide Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Exenatide Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Exenatide Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Exenatide Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Exenatide Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Exenatide Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Exenatide Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Exenatide Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Exenatide Injection Industry Trends
  2. 2.2 Exenatide Injection Industry Drivers
  3. 2.3 Exenatide Injection Industry Opportunities and Challenges
  4. 2.4 Exenatide Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Exenatide Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Exenatide Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Exenatide Injection Price (2021-2026)
  4. 3.4 Global Exenatide Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exenatide Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Exenatide Injection Company, Product Type & Application
  7. 3.7 Global Exenatide Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exenatide Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exenatide Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exenatide Injection Tier 1, Tier 2, and Tier 3
4 Exenatide Injection Regional Status and Outlook
  1. 4.1 Global Exenatide Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Exenatide Injection Historic Market Size by Region
  3. 4.2.1 Global Exenatide Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Exenatide Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Exenatide Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Exenatide Injection Forecasted Market Size by Region
  7. 4.3.1 Global Exenatide Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Exenatide Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Exenatide Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Exenatide Injection by Application
  1. 5.1 Exenatide Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Exenatide Injection Market Size by Application
  6. 5.2.1 Global Exenatide Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Exenatide Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Exenatide Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Exenatide Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Exenatide Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Exenatide Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Exenatide Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Exenatide Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lilly
  2. 6.1.1 Lilly Company Information
  3. 6.1.2 Lilly Business Overview
  4. 6.1.3 Lilly Exenatide Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lilly Exenatide Injection Product Portfolio
  6. 6.1.5 Lilly Recent Developments
  7. 6.2 Chenfei Pharmaceutical
  8. 6.2.1 Chenfei Pharmaceutical Company Information
  9. 6.2.2 Chenfei Pharmaceutical Business Overview
  10. 6.2.3 Chenfei Pharmaceutical Exenatide Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chenfei Pharmaceutical Exenatide Injection Product Portfolio
  12. 6.2.5 Chenfei Pharmaceutical Recent Developments
  13. 6.3 Baxter Pharmaceutical
  14. 6.3.1 Baxter Pharmaceutical Company Information
  15. 6.3.2 Baxter Pharmaceutical Business Overview
  16. 6.3.3 Baxter Pharmaceutical Exenatide Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter Pharmaceutical Exenatide Injection Product Portfolio
  18. 6.3.5 Baxter Pharmaceutical Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Exenatide Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Exenatide Injection Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Amylin
  26. 6.5.1 Amylin Company Information
  27. 6.5.2 Amylin Business Overview
  28. 6.5.3 Amylin Exenatide Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amylin Exenatide Injection Product Portfolio
  30. 6.5.5 Amylin Recent Developments
7 North America by Country
  1. 7.1 North America Exenatide Injection Sales by Country
  2. 7.1.1 North America Exenatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Exenatide Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Exenatide Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Exenatide Injection Market Size by Country
  6. 7.2.1 North America Exenatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Exenatide Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Exenatide Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Exenatide Injection Sales by Country
  2. 8.1.1 Europe Exenatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Exenatide Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Exenatide Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Exenatide Injection Market Size by Country
  6. 8.2.1 Europe Exenatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Exenatide Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Exenatide Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Exenatide Injection Sales by Country
  2. 9.1.1 Asia-Pacific Exenatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Exenatide Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Exenatide Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Exenatide Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Exenatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Exenatide Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Exenatide Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Exenatide Injection Sales by Country
  2. 10.1.1 South America Exenatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Exenatide Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Exenatide Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Exenatide Injection Market Size by Country
  6. 10.2.1 South America Exenatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Exenatide Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Exenatide Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Exenatide Injection Sales by Country
  2. 11.1.1 Middle East and Africa Exenatide Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Exenatide Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Exenatide Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Exenatide Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Exenatide Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Exenatide Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Exenatide Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Exenatide Injection Value Chain Analysis
  2. 12.1.1 Exenatide Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Exenatide Injection Production Mode & Process
  7. 12.2 Exenatide Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Exenatide Injection Distributors
  10. 12.2.3 Exenatide Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst